naloxegol

The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

Naloxegol Drug Utilization Post Authorisation Safety Study

Naloxegol Health Outcome Post Authorisation Safety Study

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

Naloxegol US PMR CV Safety.

Colonic Motor Patterns in Healthy Volunteers

Effect of Naloxegol on Postoperative Ileus in Patients Undergoing Cardiac Surgery

Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit

Naloxegol in Cancer Opioid-Induced Constipation

Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Movantik for Opioid-Related Esophageal Disorders

Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects

Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

Study in Healthy Volunteers to Investigate the Effects of Diltiazem on the Pharmacokinetics of Naloxegol